Veradigm | Beneficio Bruto En Ventas

Precio De Mercado
4.30
Cambio Diario
-0.20 -4.44%
Mensual
-9.47%
Anual
-19.63%
Q1 Expectativa
7.75




Beneficio Bruto En Ventas Cambio Fecha
Alcidion AUD 15.37M 7.78M 2024-12
Ambu A/S DKK 947M 68M 2025-12
Amplifon EUR 103.17M 44.14M 2025-09
Cardinal Health USD 2.4B 78M 2025-12
Centene USD 2.14B 796M 2025-12
Charles River Laboratories USD 311.39M 6.77M 2025-09
Cigna USD 56.45B 50.29B 2025-09
Convatec Group USD 660.5M 348.95M 2024-12
CVS Health USD 13.57B 239M 2025-12
Diasorin EUR 181.08M 19.92M 2025-09
Elevance Health USD 11.68B 889M 2025-12
General Electric Aerospace USD 3.8B 118M 2025-12
Gulf Medical Proj AED 46.22M 8.48M 2025-03
Humana USD 4.82B 754M 2025-06
IQVIA Holdings USD 1.12B 32M 2025-12
Laboratory Of America USD 1.03B 21.1M 2025-09
Maximus USD 318.67M 14.88M 2025-12
McKesson USD 3.68B 143M 2025-12
Med Life RON 636.25M 40.3M 2025-06
Molina Healthcare USD 1.2B 193M 2025-12
Omnicell USD 130.32M 4.18M 2025-12
Oriola-kd EUR 40.2M 2.1M 2025-09
Owens Minor USD 526.01M 53.75M 2025-03
Quest Diagnostics USD 873M 37M 2025-12
Rede D'or Sao Luiz BRL 3.36B 441.22M 2025-09
Siemens Healthineers EUR 2.08B 299M 2025-12
Sonova Holding CHF 1.28B 205.2M 2025-12
Supermax Corporation Bhd MYR -143.15M 161.11M 2025-09
UnitedHealth USD 20.64B 77.96B 2025-09
Veeva Systems USD 629.59M 17.83M 2025-09
Veradigm USD 83.44M 3.95M 2022-09
Xerox USD 441M 15M 2025-06


Veradigm Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.